Autoantibodies as potential biomarkers of high grade immune-related adverse events (irAEs) in metastatic melanoma patients treated with check point inhibitors (ICIs)

A. Gandhi, J. Taylor, M. Morici, A. Reid, T. Meniawy, M. A. Khattak, M. Millward, E. S. Gray, P. Zaenker

Research output: Contribution to journalAbstract/Meeting Abstractpeer-review

Original languageEnglish
Pages (from-to)S597-S597
Number of pages1
JournalAnnals of Oncology
Issue number7
Publication statusPublished - Sep 2022
EventAnnual Meeting of the European-Society-for-Medical-Oncology (ESMO) -
Duration: 9 Sep 202213 Sep 2022

Cite this